NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 130 filers reported holding NOVAVAX INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $28,000 | -74.8% | 50,773 | -15.9% | 0.00% | – |
| Q4 2018 | $111,000 | -2.6% | 60,373 | 0.0% | 0.00% | – |
| Q3 2018 | $114,000 | +56.2% | 60,373 | +11.0% | 0.00% | – |
| Q2 2018 | $73,000 | -47.9% | 54,373 | -18.5% | 0.00% | – |
| Q1 2018 | $140,000 | +66.7% | 66,731 | -1.9% | 0.00% | – |
| Q4 2017 | $84,000 | +5.0% | 68,031 | -3.3% | 0.00% | – |
| Q3 2017 | $80,000 | -1.2% | 70,381 | 0.0% | 0.00% | – |
| Q2 2017 | $81,000 | -4.7% | 70,381 | +6.0% | 0.00% | – |
| Q1 2017 | $85,000 | +34.9% | 66,381 | +32.4% | 0.00% | – |
| Q4 2016 | $63,000 | -3.1% | 50,143 | +61.3% | 0.00% | – |
| Q3 2016 | $65,000 | -88.3% | 31,081 | -59.3% | 0.00% | -100.0% |
| Q2 2016 | $556,000 | +64.0% | 76,454 | +16.3% | 0.00% | +100.0% |
| Q1 2016 | $339,000 | +58.4% | 65,713 | +157.4% | 0.00% | 0.0% |
| Q4 2015 | $214,000 | – | 25,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |